The latest announcement is out from Summit Therapeutics (SMMT).
Summit Therapeutics Inc. has undergone a significant leadership change, with Ankur Dhingra stepping down as CFO, and the COO, Manmeet Soni, taking over the role. Soni will receive a $100,000 bonus and stock options as part of his new responsibilities. Additionally, Bhaskar Anand has been appointed as Chief Accounting Officer, bringing over two decades of experience to the position, including his recent work at Reata Pharmaceuticals and involvement in a major merger with Biogen. Both Soni and Anand are seasoned professionals with strong backgrounds in finance and leadership within the pharmaceutical industry.
See more data about SMMT stock on TipRanks’ Stock Analysis page.
